Market Overview:
The global loperamide market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of diarrhea, increasing demand for over-the-counter drugs, and growing awareness about loperamide products. Based on type, the global loperamide market is segmented into capsule, tablet, solution, and granule. The capsule segment is expected to account for the largest share of the global loperamide market in 2018. This can be attributed to its ease of use and high patient compliance rates. Based on application, the global loperamide market is segmented into hospitals, clinics, and pharmacies.
Product Definition:
Loperamide is a synthetic opioid agonist used as an antidiarrheal agent. It decreases the motility of the gastrointestinal tract, presumably by blocking action of acetylcholine at smooth muscle cells in the gut wall. Loperamide is also effective in controlling postoperative ileus and chronic diarrhea due to radiation therapy or chemotherapy.
Capsule:
Capsule is a small package that contains medicine and it's used to treat diarrhea. It works by replacing the drug in the body which helps to reduce diarrhea. Capsules are available in different forms such as film, enteric coated, effervescent etc.
Tablet:
Tablet is a form of oral drug delivery system which comprises small pieces of solid or powdered medicine. It is designed to be consumed by mouth and it disintegrates in the stomach acids, thereby releasing the drug into the body. The tablet has a coating that protects it from disintegrating in the acidic environment of the stomach and hence remains intact until it reaches an intestine to be absorbed into the body.
Application Insights:
The market is segmented by application into hospitals, clinics, and pharmacies. Hospitals held the largest share of the global loperamide market in 2017 owing to factors such as high usage rates and a large patient base. The product is widely used for the treatment of diarrhea due to various causes including antibiotic-associated diarrhea, rotavirus infection among others. Increasing awareness about these products among healthcare professionals has also positively influenced their demand globally.
Clinics are expected to witness significant growth over the forecast period owing to rising consumer awareness regarding proper hygiene practices along with increasing incidences of travelers¢â‚¬â„¢ diarrhea across the globe. Moreover, growing penetration of online retail stores that offer fast delivery services will further boost their sales in near future as consumers prefer purchasing medicines from such stores due to bulk discounts offered on a purchase basis by these retailers which can be redeemed later when purchasing other medicines through regular pharmacies or online shops.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to high demand for loperamide from patients suffering from diarrhea and other gastrointestinal disorders. In addition, increasing cases of drug-resistant diarrhea are anticipated to boost product demand in this region.
Asia Pacific is expected to be one of the fastest growing regions over the forecast period owing to rising healthcare expenditure, improving infrastructure and economic development coupled with an increase in patient awareness levels regarding chronic diseases such as diabetes and diarrhea. These factors are likely to contribute toward regional growth during the estimated time span.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for loperamide in the coming years.
- Rising prevalence of diarrhea: The prevalence of diarrhea is on the rise due to various factors such as changing lifestyle, food habits, and environmental conditions. This is expected to boost the demand for loperamide in the near future.
- Growing awareness about loperamide: There has been a growing awareness about loperamide in recent years owing to its various benefits over other drugs used for treating diarrhea. This is likely to propel its demand in the coming years.
- Technological advancements: The technological advancements taking place in the field of drug delivery are likely to provide new opportunities for growth of Loperamide market during forecast period 2017-2025 .This will help improve patient compliance and increase usage rates over traditional therapies .
Scope Of The Report
Report Attributes
Report Details
Report Title
Loperamide Market Research Report
By Type
Capsule, Tablet, Solution, Granule
By Application
Hospitals, Clinics, Pharmacies
By Companies
Johnson & Johnson, Mylan, Bionpharma, Teva, Perrigo, Sun Pharmaceutical, Aurobindo Pharma, LNK International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Loperamide Market Report Segments:
The global Loperamide market is segmented on the basis of:
Types
Capsule, Tablet, Solution, Granule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Mylan
- Bionpharma
- Teva
- Perrigo
- Sun Pharmaceutical
- Aurobindo Pharma
- LNK International
Highlights of The Loperamide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Tablet
- Solution
- Granule
- By Application:
- Hospitals
- Clinics
- Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Loperamide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Loperamide is a medication used to treat diarrhea. It works by slowing down the movement of food through the intestines.
Some of the major players in the loperamide market are Johnson & Johnson, Mylan, Bionpharma, Teva, Perrigo, Sun Pharmaceutical, Aurobindo Pharma, LNK International.
The loperamide market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Loperamide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Loperamide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Loperamide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Loperamide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Loperamide Market Size & Forecast, 2020-2028
4.5.1 Loperamide Market Size and Y-o-Y Growth
4.5.2 Loperamide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Capsule
5.2.2 Tablet
5.2.3 Solution
5.2.4 Granule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Loperamide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Loperamide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Capsule
9.6.2 Tablet
9.6.3 Solution
9.6.4 Granule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Capsule
10.6.2 Tablet
10.6.3 Solution
10.6.4 Granule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Capsule
11.6.2 Tablet
11.6.3 Solution
11.6.4 Granule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Capsule
12.6.2 Tablet
12.6.3 Solution
12.6.4 Granule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Capsule
13.6.2 Tablet
13.6.3 Solution
13.6.4 Granule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Loperamide Market: Competitive Dashboard
14.2 Global Loperamide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Mylan
14.3.3 Bionpharma
14.3.4 Teva
14.3.5 Perrigo
14.3.6 Sun Pharmaceutical
14.3.7 Aurobindo Pharma
14.3.8 LNK International
